This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
West’s new flexible line for pens and autoinjectors, launching Q1 2026, will streamline assembly, labeling, packaging and testing for clinical volumes and drive cost efficiency.
Pharmacy workforce planning, digital integration and sustainability in healthcare have been highlighted as central themes in the Royal Pharmaceutical Society (RPS) manifestos for the 2026 devolved elections in Wales and Scotland. A version of this article was originally published by our sister publication The Pharmacist.
Recent Videos Related Content FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1 Killian Meara July 10th 2025 Article The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026.
What a waste […] The post Uniform MPJE From NABP – Coming In 2026 appeared first on Med Ed 101. I have licenses in 3 states and that is plenty for me to keep track of. Some pharmacists are having to obtain double-digit licenses to perform their role as a pharmacist.
billion in estimated out-of-pocket savings for people with Medicare prescription drug coverage when the negotiated prices are set to go into effect in 2026.
However, plans for an additional rise in 2026 have been put on hold to allow for further reflection on concerns raised by registrants. When the uplift was first mooted by the GPhC in January, it also proposed to rise fees by a further 6% from September 2026 as part of a move to set fees for the next two years.
Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than a decade, the Congressional Budget Office (CBO) ventured to estimate the budgetary effects of such a policy for older Americans starting in 2026 for the very first time in a report published in October.
Following a meeting of the Vaccines and Related Biological Products Advisory Committee, the FDA announced their recommendation of COVID-19 vaccines targeting LP.8.1, a strain of the JN.1 1 variant that has become dominant in the US.
2026 Edition. Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips? Sign up today for our free Drug Topics newsletter. REFERENCES 1. Yellow Book. Updated April 23, 2025. Accessed May 16, 2025. The Immunization Action Coalition. Travel Vaccines. Updated October 11, 2024.
"I think it's really important, as we move to 2026 and beyond, we figure out ways to help pharmacies ease that burden and diversify their business." There's going to be reimbursement pressures that pharmacies are faced with when it comes to script revenue," Flaugher said.
The 15% tariff on pharmaceutical imports from the European Union is not a short term inconvenience, it represents a structural shift in the economics of the US pharmaceutical market.
The European Pharmacopoeia’s decision to abolish rabbit pyrogen testing by 2026 exemplifies this trend” The pharmaceutical industry’s testing landscape continues to evolve, particularly where animal-derived methods face increasing scrutiny.
We are also planning our 2026 truly International Virtual Symposium in March – a 24-hour event that will bring oncology pharmacy professionals together from around the world to learn from each other, share best practices and discuss emerging trends.’
Courts cleared the way for Amgen’s Pavblu to launch, and Regeneron agreed to allow Biocon Biologics to launch Yesafili in the second half of 2026. The company also filed lawsuits against several potential competitors, staving off immediate competition from four of five approved biosimilar products.
Kennedy Jr’s newly appointed vaccine panel members recommended against including the preservative thimerosal in 2025-2026 influenza vaccines. At a March 2025 meeting earlier this year, the FDA recommended similar compositions for 2025-2026 trivalent influenza vaccines, with 1 change to one of the strains. Accessed July 7, 2025.
BioOrbit aims to kick off pre-clinical trials to study protein crystals for monoclonal antibodies (mAbs) produced in a pharmaceutical factory in space in 2026. Then, we will need to run pre-clinical trials of these crystals, which will be in 2026 or 2027. Image credit: Rini. com/ Shutterstock.
Patients should be informed that the 2025-2026 influenza vaccines will be trivalent, covering 2 influenza A strains (H1N1 and an updated H3N2) and 1 B/Victoria lineage strain, as the B/Yamagata lineage is no longer circulating. 5 This option should be available for patients for the 2025-2026 flu season.
The spending review sets out planned day-to-day spending totals for all Government departments for the years from 2026/27 to 2028/29, and investment spending plans for a further year (from 2026/27 to 2029/30). This will build on the near £1bn reduction in agency spend delivered in 2024/25.’
Shots: The US FDA has approved the IND application of NVC-001 to treat LMNA-related dilated cardiomyopathy (LMNA DCM), enabling a P-I/II trial to start in early 2026 Preclinical studies showed that NVC-001 significantly improved survival and cardiac function.
[link] Download Issue PDF Download RIS Articles in this issue Flu Fighters: Pharmacists Partnering to Protect Communities Navigating State Standing Orders and Collaborative Practice Agreements: Preparing for the 2025-2026 Influenza Season Moving the Needle From Vaccine Hesitancy to Vaccine Acceptance Pharmacists Can Simplify the Vaccine Schedule Under (..)
percent between 2026 to 2033; last year the market valued $3.25 Research by Verified Market Reports, Inc has forecasted that the automated and rapid microbiological testing market will reach $5.89 billion by 2033. It is expected to grow at a CAGR of 7.25 Overall, they predict the global pharmaceutical market will value $1.5 trillion by 2028.
Curie.Bio’s new fund will help the organization double its investing over the next two years: The aim is to invest in between 15 and 20 biotechs this year and up to 25 companies in 2026, the founders told STAT exclusively. Continue to STAT+ to read the full story…
Bristol Myers Squibb Application for Psoriatic Arthritis Drug Accepted for Review in Four Regions Patrick Lavery July 22nd 2025 Article Sotyktu (deucravacitinib) has been assigned a Prescription Drug User Fee Act (PDUFA) goal date of March 6, 2026.
Mary Dzhuryan is a class of 2026 PharmD candidate at the USC Alfred E. Mehrnaz Razavi Vakhshoori is a class of 2026 PharmD candidate at the USC Alfred E. The recent application was granted both priority review and orphan drug designation. Mann School of Pharmacy and Pharmaceutical Sciences in Los Angeles.
SHOW MORE Lessons From the Past Season Could Strengthen Prevention and Drive Vaccinations for 2025-2026 The 2024-2025 influenza season emerged as one of the most severe in recent history, catching both the public and health care professionals off guard.
The RPS has also announced work with the NHS Quality Assurance committee, Association of Pharmacy Technicians UK (APTUK) and regulators of aseptic services to update its 2016 standards for the quality assurance of aseptic preparation services , to be ready by the end of 2026. ‘We
For the 2025-2026 formula, the FDA Vaccines and Related Biological Products Advisory Committee recommended that the COVID-19 vaccines closely match currently circulating viruses, and the vaccine should include monovalent JN.1 COVID-19 vaccines (2025-2026 formula) for use in the United States beginning in fall 2025. 2025.23557 2.
CVS Health will not sell its Aetna health plans in the Affordable Care Act’s individual marketplaces in 2026, marking the second time in the past decade that Aetna has given up on ACA coverage. CVS expects to lose up to $400 million this year in its ACA plans.
1-4 About the Author Sinem Yasil is a 2026 PharmD candidate at the South College School of Pharmacy in Knoxville, Tennessee. Apixaban, edoxaban, and rivaroxaban inhibit factor Xa, while dabigatran inhibits thrombin, achieving similar anticoagulant effects. 5 A CBC provides information on an individual’s hematologic status.
The application window for the 2026-27 fellow cycle will open in September. After graduating in May, Melody will further her commitment to pharmacy quality and innovation as the 2025-2026 Executive Fellow at PQA. PQA will welcome Melody Evans and Lauren Moy in June for the 2025-26 year. Learn more about her in this Q&A.
USP plans to continue expanding its advanced technology footprint into an additional 8,000 square foot laboratory in 2026. The Advanced Technologies Lab is the latest of USP’s investments in advanced manufacturing technologies. Learn more about USP’s supply chain solutions.
Martina Nasralla is a class of 2026 PharmD candidate at the University of Southern California Alfred E. Melissa Martinez, PharmD, is pursuing a doctoral degree in clinical and experimental therapeutics through the dual PharmD/PhD program at University of Southern California Alfred E.
27, 2026 Scheduled FDA town halls on DSCSA phaseouts. 27, 2026, respectively. Staggered extension deadlines via FDA exemptions : In October 2024 , the FDA issued phased deadlines for remaining trading partners relying on stabilization exemptions: Manufacturers and repackagers had until May 27, 2025 Wholesale distributors until Aug.
GERTEIS Insights Sections Deals Jobs Filings Patents Social Media Latest Immedica to buy Marinus Pharmaceuticals for $151m Private equity deals in pharmaceutical in Canada remained flat in Q3 2024 Q3 2024 update: artificial intelligence related private equity activity in the pharmaceutical industry Companies Sections Company A-Z Company Categories (..)
PQA is developing its next strategic plan, Blueprint PQA 2030, which will guide the organization’s work from 2026 through 2030. Welcome to Five For Friday! The proposed goals build on and continue key elements of PQA’s current strategic plan, Blueprint PQA 2025 and will be the focus of the 2025 PQA Leadership Summit.
For instance, the MFP is expected to affect approximately 10 drugs in 2026, with the list expanding annually, potentially creating a $22,000 monthly financial impact for average retail pharmacies.
Related Videos Related Content Advertisement July 27th 2025 Study Explores the Survival Advantage of GLP-1s in Cancer Patients With Diabetes Kennedy Ferruggia, Assistant Editor July 10th 2025 Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike Gustavo Alva, MD Luke Halpern, Assistant Editor July 26th 2025 Carefully Monitor (..)
Related Videos Related Content Advertisement July 4th 2025 Shingles and RSV Vaccines Show Promise Against Dementia Kennedy Ferruggia, Assistant Editor May 28th 2025 Pharmacy Focus: Navigating Seasonal Allergies Luke Halpern, Assistant Editor Derek Webb, PharmD July 2nd 2025 FDA Issues Complete Response Letter to Manufacturer of OLC, Treatment for CKD-Related (..)
Related Videos Related Content Advertisement June 11th 2025 Study Finds Depression May Increase Risk of Developing Dementia Gillian McGovern, Associate Editor July 10th 2025 Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike Gustavo Alva, MD Luke Halpern, Assistant Editor June 8th 2025 Ambulatory Pharmacy in Action: House (..)
Nieto is a 2026 PharmD Candidate at the University of Connecticut School of Pharmacy in Storrs, CT. Literature—particularly, an analysis of 20,000 United States adults—suggests a higher risk of cardiovascular disease mortality in those who restricted eating to less than 8 hours per day; additional studies are needed to confirm these findings.
Growing budgetary pressure is a central theme in France as it prepares for the publication of the government's 2026 Social Security Finance Bill (PLFSS).
The UKPPLAB is actively discussing how it can build a sustainable and effective future model of pharmacy professional leadership in the light of the vote in favour of the proposals to establish the RPS as the Royal College of Pharmacy in 2026 and is encouraging pharmacy professionals to get in touch to share their views.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content